|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.174 0.000 (0.000%) Profitability Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| ROAA (%) | -15.222% | -35.978% | -20.713% | -7.307% | -18.164% |
| ROAE (%) | N/A | -204.430% | -53.978% | -15.230% | -32.796% |
| Return on Capital Employed (%) | N/A | -118.670% | -41.462% | -14.732% | -29.900% |
Margin Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Gross Profit Margin (%) | 41.237% | 28.276% | 39.472% | 39.450% | 44.164% |
| EBITDA Margin (%) | -32.084% | -115.490% | -44.688% | -28.585% | -39.932% |
| Pre-tax Profit Margin (%) | -58.021% | -137.647% | -61.603% | -42.198% | -78.601% |
| Net Profit Margin (%) | -57.851% | -135.806% | -61.257% | -25.032% | -77.135% |
Liquidity Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Current Ratio (X) | 0.312 X | 0.427 X | 0.785 X | 0.506 X | 1.150 X |
| Quick Ratio (X) | 0.268 X | 0.387 X | 0.699 X | 0.445 X | 1.067 X |
Leverage Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Total Liabilities / Total Assets(%) | 107.385% | 96.530% | 68.062% | 52.471% | 42.757% |
| Total Debt / Total Assets (%) | 69.885% | 63.376% | 44.499% | 31.109% | 22.905% |
| Net Debt / Total Assets (%) | 66.920% | 57.697% | 30.068% | 25.234% | 8.250% |
| Total Debt / Shareholders' Funds (%) | N/A | N/A | 149.650% | 67.837% | 45.615% |
| Long Term Debt / Shareholders' Funds (%) | N/A | N/A | 73.569% | 1.728% | 1.658% |
| Net Debt / Shareholders' Funds (%) | N/A | N/A | 101.120% | 55.027% | 16.429% |
| Net Cash / (Debt) ($) | (368.272M) | (350.416M) | (266.916M) | (258.581M) | (80.183M) |
| Net Cash / (Debt) per share ($) | (0.131) | (0.125) | (0.095) | (0.092) | (0.029) |
| Total Debt / Capital Employed (%) | N/A | 169.843% | 82.691% | 64.378% | 39.440% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Inventory Turnover (Day) | 81.230 Day | 65.352 Day | 63.765 Day | 68.787 Day | 94.575 Day |
| Receivables Turnover (Day) | 59.224 Day | 63.205 Day | 60.807 Day | 78.264 Day | 94.624 Day |
| Payables Turnover (Day) | 36.535 Day | 42.650 Day | 37.362 Day | 42.486 Day | 51.814 Day |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -88,107,000 |
| %Change | -67.239% |
| EPS / (LPS) | HKD -0.031 |
| NBV Per Share ($) | HKD -0.030 |